Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 2 minute read Pharma Industry News Eusa Pharma completes $115m acquisition of Sylvant for iMCD treatment Eusa Pharma has successfully acquired the global rights to Sylvant (siltuximab), a drug used in the treatment of… bypharmanewsdailyJanuary 20, 2019